Do analysts recommend API or DH?

Definitive Healthcare has a consensus target price of $2.47, suggesting a potential upside of 191.20%. Given Definitive Healthcare's higher possible upside, analysts clearly believe Definitive Healthcare is more favorable than Agora. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agora 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Definitive Healthcare 4 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 1.89

Do analysts prefer XNET or DH?

Definitive Healthcare has a consensus price target of $2.47, indicating a potential upside of 191.20%. Given Definitive Healthcare's higher possible upside, analysts plainly believe Definitive Healthcare is more favorable than Xunlei. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Xunlei 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Definitive Healthcare 4 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 1.89

Definitive Healthcare (DH) Competitors

$0.85 +0.05 (+5.76%)

Closing price 07/14/2026 04:00 PM Eastern

Extended Trading

$0.85 +0.00 (+0.04%)

As of 09:02 AM Eastern

Compare

DH vs. SLP, TLS, PERI, API, and XNET

Should you buy Definitive Healthcare stock or one of its competitors? MarketBeat compares Definitive Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Definitive Healthcare include Simulations Plus (SLP), Telos (TLS), Perion Network (PERI), Agora (API), and Xunlei (XNET). These companies are all part of the "computer software" industry.

How does Definitive Healthcare compare to Simulations Plus?

Simulations Plus (NASDAQ:SLP) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Simulations Plus presently has a consensus price target of $17.25, suggesting a potential downside of 5.32%. Definitive Healthcare has a consensus price target of $2.47, suggesting a potential upside of 191.20%. Given Definitive Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Definitive Healthcare is more favorable than Simulations Plus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Simulations Plus	1 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.88
Definitive Healthcare	4 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	1.89

Simulations Plus has higher earnings, but lower revenue than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Simulations Plus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Simulations Plus	$79.18M	4.66	-$64.72M	$0.40	45.55
Definitive Healthcare	$241.52M	0.37	-$138.93M	-$1.62	N/A

In the previous week, Simulations Plus had 12 more articles in the media than Definitive Healthcare. MarketBeat recorded 13 mentions for Simulations Plus and 1 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 1.89 beat Simulations Plus' score of 0.64 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Simulations Plus	Positive
Definitive Healthcare	Very Positive

78.1% of Simulations Plus shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 19.1% of Simulations Plus shares are held by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Simulations Plus has a net margin of 9.88% compared to Definitive Healthcare's net margin of -76.04%. Simulations Plus' return on equity of 13.50% beat Definitive Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Simulations Plus	9.88%	13.50%	12.45%
Definitive Healthcare	-76.04%	4.04%	1.99%

Simulations Plus has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, indicating that its share price is 33% more volatile than the broader market.

Summary

Simulations Plus beats Definitive Healthcare on 9 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to Telos?

Telos (NASDAQ:TLS) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

Telos currently has a consensus target price of $7.10, suggesting a potential upside of 44.60%. Definitive Healthcare has a consensus target price of $2.47, suggesting a potential upside of 191.20%. Given Definitive Healthcare's higher probable upside, analysts plainly believe Definitive Healthcare is more favorable than Telos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Telos	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Definitive Healthcare	4 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	1.89

Telos has higher earnings, but lower revenue than Definitive Healthcare. Telos is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Telos	$164.80M	2.23	-$36.55M	-$0.35	N/A
Definitive Healthcare	$241.52M	0.37	-$138.93M	-$1.62	N/A

In the previous week, Telos had 5 more articles in the media than Definitive Healthcare. MarketBeat recorded 6 mentions for Telos and 1 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 1.89 beat Telos' score of 0.95 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Telos	Positive
Definitive Healthcare	Very Positive

Telos has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, indicating that its stock price is 33% more volatile than the broader market.

62.1% of Telos shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 14.9% of Telos shares are owned by insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Telos has a net margin of -14.25% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Telos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Telos	-14.25%	-11.95%	-8.45%
Definitive Healthcare	-76.04%	4.04%	1.99%

Summary

Definitive Healthcare beats Telos on 10 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to Perion Network?

Definitive Healthcare (NASDAQ:DH) and Perion Network (NASDAQ:PERI) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 68.1% of Perion Network shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by insiders. Comparatively, 2.8% of Perion Network shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Perion Network had 2 more articles in the media than Definitive Healthcare. MarketBeat recorded 3 mentions for Perion Network and 1 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 1.89 beat Perion Network's score of 1.08 indicating that Definitive Healthcare is being referred to more favorably in the media.

Company	Overall Sentiment
Definitive Healthcare	Very Positive
Perion Network	Positive

Perion Network has a net margin of -2.17% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Perion Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-76.04%	4.04%	1.99%
Perion Network	-2.17%	3.34%	2.50%

Perion Network has higher revenue and earnings than Definitive Healthcare. Perion Network is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.37	-$138.93M	-$1.62	N/A
Perion Network	$439.93M	0.83	-$7.93M	-$0.25	N/A

Definitive Healthcare has a beta of 1.33, indicating that its share price is 33% more volatile than the broader market. Comparatively, Perion Network has a beta of 1.17, indicating that its share price is 17% more volatile than the broader market.

Definitive Healthcare currently has a consensus price target of $2.47, suggesting a potential upside of 191.20%. Perion Network has a consensus price target of $13.88, suggesting a potential upside of 48.55%. Given Definitive Healthcare's higher possible upside, equities analysts clearly believe Definitive Healthcare is more favorable than Perion Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	4 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	1.89
Perion Network	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Perion Network beats Definitive Healthcare on 9 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to Agora?

Agora (NASDAQ:API) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer software companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Agora has higher earnings, but lower revenue than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Agora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agora	$141.06M	2.46	$9.53M	$0.10	39.80
Definitive Healthcare	$241.52M	0.37	-$138.93M	-$1.62	N/A

Definitive Healthcare has a consensus target price of $2.47, suggesting a potential upside of 191.20%. Given Definitive Healthcare's higher possible upside, analysts clearly believe Definitive Healthcare is more favorable than Agora.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agora	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Definitive Healthcare	4 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	1.89

In the previous week, Agora and Agora both had 1 articles in the media. Definitive Healthcare's average media sentiment score of 1.89 beat Agora's score of 1.87 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Agora	Very Positive
Definitive Healthcare	Very Positive

Agora has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, suggesting that its stock price is 33% more volatile than the broader market.

Agora has a net margin of 7.03% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Agora's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agora	7.03%	1.82%	1.43%
Definitive Healthcare	-76.04%	4.04%	1.99%

40.4% of Agora shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Definitive Healthcare beats Agora on 9 of the 15 factors compared between the two stocks.

How does Definitive Healthcare compare to Xunlei?

Xunlei (NASDAQ:XNET) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Xunlei has higher revenue and earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Xunlei, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Xunlei	$494.81M	0.74	$1.05B	$13.67	0.42
Definitive Healthcare	$241.52M	0.37	-$138.93M	-$1.62	N/A

Definitive Healthcare has a consensus price target of $2.47, indicating a potential upside of 191.20%. Given Definitive Healthcare's higher possible upside, analysts plainly believe Definitive Healthcare is more favorable than Xunlei.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Xunlei	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Definitive Healthcare	4 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	1.89

Xunlei has a beta of 1.12, indicating that its share price is 12% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, indicating that its share price is 33% more volatile than the broader market.

Xunlei has a net margin of 185.71% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Xunlei's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Xunlei	185.71%	1.47%	1.24%
Definitive Healthcare	-76.04%	4.04%	1.99%

5.1% of Xunlei shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 21.7% of Xunlei shares are owned by insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Xunlei had 1 more articles in the media than Definitive Healthcare. MarketBeat recorded 2 mentions for Xunlei and 1 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 1.89 beat Xunlei's score of 0.94 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Xunlei	Positive
Definitive Healthcare	Very Positive

Summary

Xunlei beats Definitive Healthcare on 9 of the 17 factors compared between the two stocks.

Get Definitive Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DH vs. The Competition

Export

Metric	Definitive Healthcare	INTERNET SOFTWARE Industry	Computer Sector	NASDAQ Exchange
Market Cap	$84.68M	$18.19B	$38.47B	$12.44B
Dividend Yield	N/A	3.41%	3.19%	8.42%
P/E Ratio	-0.52	67.86	170.28	24.38
Price / Sales	0.37	37.03	597.33	91.92
Price / Cash	0.41	82.66	45.87	59.36
Price / Book	0.32	6.90	9.53	6.33
Net Income	-$138.93M	$385.08M	$1.07B	$331.02M
7 Day Performance	4.53%	1.76%	0.29%	-0.33%
1 Month Performance	5.56%	4.96%	-1.90%	-1.29%
1 Year Performance	-78.51%	-8.69%	141.76%	21.30%

Definitive Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DH Definitive Healthcare	3.5966 of 5 stars	$0.85 +5.8%	$2.47 +191.2%	-78.9%	$84.68M	$241.52M	N/A	970	Positive News
SLP Simulations Plus	2.0007 of 5 stars	$18.27 -0.5%	$19.88 +8.8%	+4.3%	$369.12M	$79.18M	N/A	160	Earnings Report
TLS Telos	3.4109 of 5 stars	$4.88 -1.3%	$7.10 +45.6%	+76.0%	$364.00M	$164.80M	N/A	850
PERI Perion Network	4.3218 of 5 stars	$9.32 +0.5%	$13.88 +49.0%	-14.9%	$363.37M	$439.93M	N/A	420	Positive News
API Agora	2.2664 of 5 stars	$4.17 +0.8%	N/A	+2.6%	$362.82M	$141.06M	41.55	1,310	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DH) was last updated on 7/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Definitive Healthcare (DH) Competitors

DH vs. SLP, TLS, PERI, API, and XNET

How does Definitive Healthcare compare to Simulations Plus?

Summary

How does Definitive Healthcare compare to Telos?

Summary

How does Definitive Healthcare compare to Perion Network?

Summary

How does Definitive Healthcare compare to Agora?

Summary

How does Definitive Healthcare compare to Xunlei?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Definitive Healthcare (DH) Competitors

DH vs. SLP, TLS, PERI, API, and XNET

How does Definitive Healthcare compare to Simulations Plus?

Do analysts prefer SLP or DH?

Which has preferable earnings and valuation, SLP or DH?

Does the media favor SLP or DH?

Do institutionals & insiders hold more shares of SLP or DH?

Is SLP or DH more profitable?

Which has more volatility and risk, SLP or DH?

Summary

How does Definitive Healthcare compare to Telos?

Do analysts prefer TLS or DH?

Which has stronger valuation and earnings, TLS or DH?

Does the media favor TLS or DH?

Which has more risk & volatility, TLS or DH?

Do insiders & institutionals hold more shares of TLS or DH?

Is TLS or DH more profitable?

Summary

How does Definitive Healthcare compare to Perion Network?

Do institutionals & insiders hold more shares of DH or PERI?

Does the media favor DH or PERI?

Is DH or PERI more profitable?

Which has higher valuation & earnings, DH or PERI?

Which has more volatility and risk, DH or PERI?

Do analysts rate DH or PERI?

Summary

How does Definitive Healthcare compare to Agora?

Which has higher earnings & valuation, API or DH?

Do analysts recommend API or DH?

Does the media favor API or DH?

Which has more volatility and risk, API or DH?

Is API or DH more profitable?

Do institutionals and insiders hold more shares of API or DH?

Summary

How does Definitive Healthcare compare to Xunlei?

Which has stronger valuation and earnings, XNET or DH?

Do analysts prefer XNET or DH?

Which has more volatility and risk, XNET or DH?

Is XNET or DH more profitable?

Do insiders and institutionals have more ownership in XNET or DH?

Does the media prefer XNET or DH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools